Tetrahydrofolate

Tetrahydrofolate

SCHEMBL4535490

Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)NC(CCC(=O)O)C(=O)O)cc1)N2

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SOST Q9BQB4 1/20 0.78
▸ FPGS Q05932 2/20 0.69
▸ ATIC P31939 2/20 0.60
▸ GART P22102 4/20 0.58
▸ DHFR P00374 2/20 0.57
▸ MTHFD1 P11586 2/20 0.54
▸ MTHFD2 P13995 1/20 0.51
▸ KDM4E B2RXH2 1/20 0.51
▸ MEN1 O00255 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ TYMS P04818 1/20 0.51
▸ POLB P06746 1/20 0.51
▸ GAA P10253 1/20 0.51
▸ AKR1B1 P15121 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ PTGS2 P35354 1/20 0.51
▸ KMT2A Q03164 1/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ TDP1 Q9NUW8 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrahydrofolate SCHEMBL15263902 1.00 SOST (0.78) SOSTFPGSATICGARTDHFR
Tetrahydrofolate SCHEMBL21194977 1.00 SOST (0.78) SOSTFPGSATICGARTDHFR
Tetrahydrofolate SCHEMBL82453 1.00 SOST (0.78) SOSTFPGSATICGARTDHFR
Tetrahydrofolate SCHEMBL8031 1.00 SOST (0.78) SOSTFPGSATICGARTDHFR
Tetrahydrofolate SCHEMBL159230 1.00 SOST (0.78) SOSTFPGSATICGARTDHFR
Tetrahydrofolate SCHEMBL6880950 1.00 SOST (0.78) SOSTFPGSATICGARTDHFR
Tetrahydrofolate SCHEMBL3445556 0.99 SOST (0.77) SOSTFPGSATICGARTDHFR
Tetrahydrofolate SCHEMBL21248600 0.99 SOST (0.77) SOSTFPGSATICGARTDHFR
Tetrahydrofolate SCHEMBL19376762 0.99 SOST (0.77) SOSTFPGSATICGARTDHFR
Tetrahydrofolate SCHEMBL3404283 0.99 SOST (0.77) SOSTFPGSATICGARTDHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130259882-A1 Conjugate of Folate and Antibody Preparation Method and Use Thereof ZHEJIANG JIANFENG HANSHENG BIOSCIENCES CO., LTD. (CN) 2013-10-03 — — US disclosed
EP-2637649-A2 COMPOUNDS AND METHODS FOR TREATING PAIN Akron Molecules GmbH (AT) 2013-09-18 — — EP disclosed
WO-2012062925-A2 COMPOUNDS AND METHODS FOR TREATING PAIN AKRON MOLECULES GMBH (AT) 2012-05-18 — — WO disclosed
EP-0579806-B1 MEDICAMENT FOR THE TREATMENT AND/OR PROPHYLAXIS OF FOLATE METABOLISM DISORDERS KRAGLER PETER (DE) 1999-07-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130259882-A1 Conjugate of Folate and Antibody Preparation Method and Use Thereof FOLR1, FOLR2, DHFR SOST 2530/4885FPGS 7/4885ATIC 224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback